Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 479 of 1,261
  1. US 10391164

    Vaccines for HSV-2

    IMMUNE DESIGN CORP. · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted
  2. US 10392376

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted
  3. US 10390522

    Non-human animals having a humanized programmed cell death 1 gene

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted
  4. US 10383835

    Treatment of inflammatory disorders in non-human mammals

    The Regents of the University of California · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  5. US 10385080

    STAT6 inhibitors

    The Board of Regents of the University of Texas System · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  6. US 10383827

    Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  7. US 10383960

    Small molecule imaging of fungi by positron emission tomography scanning

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  8. US 10385031

    Substituted piperazines as selective HDAC1,2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  9. US 10385360

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  10. US 10385136

    Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

    VACCINEX, INC. · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  11. US 10385085

    Crystal forms of sialic acid or salt or solvate thereof

    Ultragenyx Pharmaceutical Inc. · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  12. US 10385070

    Chroman-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  13. US 10383952

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  14. US 10383940

    Copper-cysteamine and methods of use

    The Board of Regents of the University of Texas System · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  15. US 10383945

    Methods for DNA-dependent targeting of a cell permeant antibody

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VERTERANS AFFAIRS · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  16. US 10383943

    Compositions and related methods for the treatment of cancer

    SOUTH DAKOTA BOARD OF REGENTS · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  17. US 10383830

    Modulating antibacterial immunity via bacterial membrane-coated nanoparticles

    The Regents of the University of California · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  18. US 10383935

    Methods of making and using live attenuated viruses

    Regents of the University of Minnesota · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  19. US 10383927

    Variable epitope library compositions and methods of therapeutic and prophylactic use

    Primex Clinical Laboratories, Inc. · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  20. US 10383939

    Light-activated compositions and methods using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  21. US 10385395

    Diagnostic tools for response to 6-thiopurine therapy

    The Regents of the University of California · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  22. US 10385319

    Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  23. US 10385165

    N-maleimidyl polymer derivatives

    Nektar Therapeutics · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted
  24. CA 3089552

    PROCEDE CONTINU DE PREPARATION DE TRAZODONE

    AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA [IT] · Granted Aug 15, 2019 · Expires Aug 10, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.